Literature DB >> 26039991

hnRNP U protein is required for normal pre-mRNA splicing and postnatal heart development and function.

Junqiang Ye1, Nadine Beetz2, Sean O'Keeffe1, Juan Carlos Tapia1, Lindsey Macpherson1, Weisheng V Chen1, Rhonda Bassel-Duby3, Eric N Olson3, Tom Maniatis4.   

Abstract

We report that mice lacking the heterogeneous nuclear ribonucleoprotein U (hnRNP U) in the heart develop lethal dilated cardiomyopathy and display numerous defects in cardiac pre-mRNA splicing. Mutant hearts have disorganized cardiomyocytes, impaired contractility, and abnormal excitation-contraction coupling activities. RNA-seq analyses of Hnrnpu mutant hearts revealed extensive defects in alternative splicing of pre-mRNAs encoding proteins known to be critical for normal heart development and function, including Titin and calcium/calmodulin-dependent protein kinase II delta (Camk2d). Loss of hnRNP U expression in cardiomyocytes also leads to aberrant splicing of the pre-mRNA encoding the excitation-contraction coupling component Junctin. We found that the protein product of an alternatively spliced Junctin isoform is N-glycosylated at a specific asparagine site that is required for interactions with specific protein partners. Our findings provide conclusive evidence for the essential role of hnRNP U in heart development and function and in the regulation of alternative splicing.

Entities:  

Keywords:  N-glycosylation; RNA-seq; alternative splicing; dilated cardiomyopathy; heart development

Mesh:

Substances:

Year:  2015        PMID: 26039991      PMCID: PMC4466706          DOI: 10.1073/pnas.1508461112

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  56 in total

Review 1.  The alternative heart: impact of alternative splicing in heart disease.

Authors:  Enrique Lara-Pezzi; Jesús Gómez-Salinero; Alberto Gatto; Pablo García-Pavía
Journal:  J Cardiovasc Transl Res       Date:  2013-06-18       Impact factor: 4.132

Review 2.  Lost in transgenesis: a user's guide for genetically manipulating the mouse in cardiac research.

Authors:  Jennifer Davis; Marjorie Maillet; Joseph M Miano; Jeffery D Molkentin
Journal:  Circ Res       Date:  2012-08-31       Impact factor: 17.367

3.  Altered calsequestrin glycan processing is common to diverse models of canine heart failure.

Authors:  Sony Jacob; Naama H Sleiman; Stephanie Kern; Larry R Jones; Javier A Sala-Mercado; Timothy P McFarland; Hani H Sabbah; Steven E Cala
Journal:  Mol Cell Biochem       Date:  2013-03-01       Impact factor: 3.396

4.  Topological organization of multichromosomal regions by the long intergenic noncoding RNA Firre.

Authors:  Ezgi Hacisuleyman; Loyal A Goff; Cole Trapnell; Adam Williams; Jorge Henao-Mejia; Lei Sun; Patrick McClanahan; David G Hendrickson; Martin Sauvageau; David R Kelley; Michael Morse; Jesse Engreitz; Eric S Lander; Mitch Guttman; Harvey F Lodish; Richard Flavell; Arjun Raj; John L Rinn
Journal:  Nat Struct Mol Biol       Date:  2014-01-26       Impact factor: 15.369

5.  Deep RNA sequencing reveals dynamic regulation of myocardial noncoding RNAs in failing human heart and remodeling with mechanical circulatory support.

Authors:  Kai-Chien Yang; Kathryn A Yamada; Akshar Y Patel; Veli K Topkara; Isaac George; Faisal H Cheema; Gregory A Ewald; Douglas L Mann; Jeanne M Nerbonne
Journal:  Circulation       Date:  2014-01-15       Impact factor: 29.690

6.  RNA Bind-n-Seq: quantitative assessment of the sequence and structural binding specificity of RNA binding proteins.

Authors:  Nicole Lambert; Alex Robertson; Mohini Jangi; Sean McGeary; Phillip A Sharp; Christopher B Burge
Journal:  Mol Cell       Date:  2014-05-15       Impact factor: 17.970

7.  Integrative genome-wide analysis reveals cooperative regulation of alternative splicing by hnRNP proteins.

Authors:  Stephanie C Huelga; Anthony Q Vu; Justin D Arnold; Tiffany Y Liang; Patrick P Liu; Bernice Y Yan; John Paul Donohue; Lily Shiue; Shawn Hoon; Sydney Brenner; Manuel Ares; Gene W Yeo
Journal:  Cell Rep       Date:  2012-02-23       Impact factor: 9.423

8.  Alternative splicing regulates vesicular trafficking genes in cardiomyocytes during postnatal heart development.

Authors:  Jimena Giudice; Zheng Xia; Eric T Wang; Marissa A Scavuzzo; Amanda J Ward; Auinash Kalsotra; Wei Wang; Xander H T Wehrens; Christopher B Burge; Wei Li; Thomas A Cooper
Journal:  Nat Commun       Date:  2014-04-22       Impact factor: 14.919

9.  RNA-binding protein RBM20 represses splicing to orchestrate cardiac pre-mRNA processing.

Authors:  Henrike Maatz; Marvin Jens; Martin Liss; Sebastian Schafer; Matthias Heinig; Marieluise Kirchner; Eleonora Adami; Carola Rintisch; Vita Dauksaite; Michael H Radke; Matthias Selbach; Paul J R Barton; Stuart A Cook; Nikolaus Rajewsky; Michael Gotthardt; Markus Landthaler; Norbert Hubner
Journal:  J Clin Invest       Date:  2014-06-24       Impact factor: 14.808

10.  OLego: fast and sensitive mapping of spliced mRNA-Seq reads using small seeds.

Authors:  Jie Wu; Olga Anczuków; Adrian R Krainer; Michael Q Zhang; Chaolin Zhang
Journal:  Nucleic Acids Res       Date:  2013-04-09       Impact factor: 16.971

View more
  43 in total

Review 1.  Tbx3-Mediated Regulation of Cardiac Conduction System Development and Function: Potential Contributions of Alternative RNA Processing.

Authors:  Brian P Delisle; Yao Yu; Pavan Puvvula; Allison R Hall; Chad Huff; Anne M Moon
Journal:  Pediatr Cardiol       Date:  2019-08-01       Impact factor: 1.655

2.  Long noncoding RNA #32 contributes to antiviral responses by controlling interferon-stimulated gene expression.

Authors:  Hironori Nishitsuji; Saneyuki Ujino; Sachiyo Yoshio; Masaya Sugiyama; Masashi Mizokami; Tatsuya Kanto; Kunitada Shimotohno
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-31       Impact factor: 11.205

3.  The core spliceosomal factor U2AF1 controls cell-fate determination via the modulation of transcriptional networks.

Authors:  Abdelhamid Mahdi Laaref; Laurent Manchon; Yacine Bareche; Laure Lapasset; Jamal Tazi
Journal:  RNA Biol       Date:  2020-03-09       Impact factor: 4.652

4.  De novo mutations in HNRNPU result in a neurodevelopmental syndrome.

Authors:  T Michael Yates; Pradeep C Vasudevan; Kate E Chandler; Deirdre E Donnelly; Zornitza Stark; Simon Sadedin; Josh Willoughby; Meena Balasubramanian
Journal:  Am J Med Genet A       Date:  2017-09-25       Impact factor: 2.802

5.  Er:YAG Laser and Cyclosporin A Effect on Cell Cycle Regulation of Human Gingival Fibroblast Cells.

Authors:  Hojjat-Allah Abbaszadeh; Ali Asghar Peyvandi; Yousef Sadeghi; Akram Safaei; Mona Zamanian-Azodi; Maryam Sadat Khoramgah; Mostafa Rezaei-Tavirani
Journal:  J Lasers Med Sci       Date:  2017-06-27

Review 6.  Cardiomyocyte Maturation: New Phase in Development.

Authors:  Yuxuan Guo; William T Pu
Journal:  Circ Res       Date:  2020-04-09       Impact factor: 17.367

7.  HRPU-2, a Homolog of Mammalian hnRNP U, Regulates Synaptic Transmission by Controlling the Expression of SLO-2 Potassium Channel in Caenorhabditis elegans.

Authors:  Ping Liu; Sijie Jason Wang; Zhao-Wen Wang; Bojun Chen
Journal:  J Neurosci       Date:  2017-12-07       Impact factor: 6.167

8.  Age-dependent skeletal muscle transcriptome response to bed rest-induced atrophy.

Authors:  Ziad S Mahmassani; Paul T Reidy; Alec I McKenzie; Chris Stubben; Michael T Howard; Micah J Drummond
Journal:  J Appl Physiol (1985)       Date:  2019-01-03

9.  RBFox1-mediated RNA splicing regulates cardiac hypertrophy and heart failure.

Authors:  Chen Gao; Shuxun Ren; Jae-Hyung Lee; Jinsong Qiu; Douglas J Chapski; Christoph D Rau; Yu Zhou; Maha Abdellatif; Astushi Nakano; Thomas M Vondriska; Xinshu Xiao; Xiang-Dong Fu; Jau-Nian Chen; Yibin Wang
Journal:  J Clin Invest       Date:  2015-11-30       Impact factor: 14.808

Review 10.  Genetics of Combined Pituitary Hormone Deficiency: Roadmap into the Genome Era.

Authors:  Qing Fang; Akima S George; Michelle L Brinkmeier; Amanda H Mortensen; Peter Gergics; Leonard Y M Cheung; Alexandre Z Daly; Adnan Ajmal; María Ines Pérez Millán; A Bilge Ozel; Jacob O Kitzman; Ryan E Mills; Jun Z Li; Sally A Camper
Journal:  Endocr Rev       Date:  2016-11-09       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.